在巴勒斯坦乳腺癌幸存者的放射治疗引起的疲劳
Hussein ALMasri1, Omar Rimawi2
1Medical Imaging Department, Faculty of Health Professions, Al-Quds University, Jerusalem, Palestine.
Health psychology and behavioral medicine
|January 10, 2024
概括
与癌症相关的疲劳 (CRF) 在接受放射治疗的巴勒斯坦乳腺癌幸存者中很常见. 高等教育,离婚,年龄较小,治疗时间较长与疲劳增加相关,影响治疗坚持.
科学领域:
- 在瘤学瘤学.
- 心理社会瘤学
背景情况:
- 与癌症相关的疲劳 (CRF) 是乳腺癌幸存者中普遍存在的问题.
- 关于CRF的研究有限,特别是在接受放射治疗 (RT) 的巴勒斯坦人口中.
研究的目的:
- 评估在接受RT的巴勒斯坦乳腺癌幸存者的CRF患病率.
- 根据人口和临床变量来比较CRF水平.
- 为了确定CRF和特定患者特征之间的相关性.
主要方法:
- 使用慢性疾病治疗功能评估 - 疲劳量表 (FACIT-F) 进行评估.
- 样本包括148名乳腺癌幸存者接受RT.
- 统计分析包括单向ANOVA和皮尔森相关系数.
主要成果:
- 观察到一种中等水平的疲劳 (平均值=2.88,SD=0.84).
- 高学历,离婚状态,年龄较小,没有孩子与疲劳增加有关.
- 在疲劳与儿童数量,年龄和RT的持续时间之间发现了积极的相关性.
结论:
- 疲劳是乳腺癌幸存者在RT期间的一个重要问题.
- 早期发现疲劳对于维持治疗连续性和改善治疗结果至关重要.
- 解决疲劳问题可以提高患者对放射治疗方案的坚持.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...